A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder
Status:
Not yet recruiting
Trial end date:
2026-08-01
Target enrollment:
Participant gender:
Summary
To explore the effectiveness of n-acetyl cysteine in improving treatment outcomes for alcohol
use disorder in a double-blind randomised placebo-controlled trial.
Phase:
Phase 4
Details
Lead Sponsor:
South West Sydney Local Health District
Collaborators:
National Health and Medical Research Council, Australia Sydney Local Health District